Impact of ART in Primary HIV infection on T cell immune exhaustion in Gut- associated lymphoid tissue: Implications for HIV persistence

Similar documents
The Impact of Immunoglobulin in Acute HIV Infection on the HIV Reservoir: A Pilot Randomized Controlled Trial

PROSPECTS FOR HIV CURE IN ADULTS. Nov 11 th 2013 John Frater

CHERUB Collaborative HIV Eradication of Reservoirs: UK BRC (

Professor Jonathan Weber

HIV remission: viral suppression in the absence of ART. Sarah Fidler Brian Gazzard Lecture BHIVA 2016

HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial

UK clinicians approach to ART in primary HIV infection; comparison with the BHIVA guidelines

Engineered Immune-Mobilising Monoclonal T Cell Receptors for HIV Cure

IAS 2013 Towards an HIV Cure Symposium

Collaborative HIV Eradication of viral Reservoirs: UK BRC Scientific Workshop 4 th December 2015

Sustained HIV- 1 remission following homozygous CCR5 delta- 32 allogeneic haemopoetic stem cell transplantion

Working Group#1: Trial Endpoints, Biomarkers & Definitions

Loss of CD96 Expression as a New Biomarker for T-cell Senescence in HIV-1 Infection

Clinical Development of ABX464, drug candidate for HIV Functional Cure. Chief Medical Officer ABIVAX

Rationale for therapy at PHI

HD1 (FLU) HD2 (EBV) HD2 (FLU)

With over 20 drugs and several viable regimens, the mo6vated pa6ent with life- long access to therapy can control HIV indefinitely, elimina6ng the

Lecture 9: T-cell Mediated Immunity

Professor Anna Maria Geretti

Dr Anna Herasimtschuk

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

CROI 2016 Review: Immunology and Vaccines

The HIV Cure Agenda. CHIVA Oct Nigel Klein. Institute of Child Health and Great Ormond Street Hospital, London, UK

x Lymphocyte count /µl CD8+ count/µl 800 Calculated

Dr Charlotte-Eve Short

Dr Marta Boffito Chelsea and Westminster Hospital, London

Management of Severe Primary HIV Infection

T Cell Activation, Costimulation and Regulation

cure research HIV & AIDS

BHIVA Best of CROI Feedback Meetings BHIVA Best of CROI Feedback Meetings 2012

Can HPV, cervical neoplasia or. HIV transmission?

Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads

Inves)gación básica y curación del VIH- 1

Combined IL-21 and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques

Induction and Clearance of Latent HIV Infection:

System Biology analysis of innate and adaptive immune responses during HIV infection

Intermittent Antiretroviral Therapy (ART) Can Induce Reduction of Viral Rebounding During ART-Interruption

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients

How to best manage HIV patient?

Checkpoint inhibitors for HBV cure

Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific

Elevated expression of LAG-3, but not PD-1, is associated with impaired inkt cytokine production during chronic HIV-1 infection and treatment

Supplementary Figure 1 IL-27 IL

The potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies

Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection

Supporting Information

Theme 14 Ranking tests

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells

5/11/2017. HIV Cure Research Questions and a Few Answers

Modeling Kinetics of HBV Infection and Recommendations for Moving Forward

Alexander O. Pasternak, Mirte Scherpenisse, Ben Berkhout

Flow Cytometric Analysis of Gut Biopsies. Ian McGowan MD PhD FRCP University of Pittsburgh Pittsburgh, PA USA

Innovative diagnostics for HIV, HBV and HCV

Early Antiretroviral Therapy

Challenges of Integrating Mucosal Immune Assays into HIV Vaccine Trials KAVI

Module R: Recording the HIV Reservoir

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose

Cancer immunity and immunotherapy. General principles

Coagulation and Morbidity in Treated HIV Infection. Michael M. Lederman, MD Scott R. Inkley Professor of Medicine Case Western Reserve University

Overview of role of immunologic markers in HIV diagnosis

CD4 + T-cell-inducing HIV vaccines may have an impact on viral control

Welcome. Nanostring Immuno-Oncology Summit. September 21st, FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Addressing key gaps in cure research through identification and treatment of hyperacute HIV infection in a resource-limited setting

Supplementary Figure 1. IL-12 serum levels and frequency of subsets in FL patients. (A) IL-12

Towards an HIV Cure. Steven G. Deeks Professor of Medicine University of California, San Francisco

Professor Mark Bower Chelsea and Westminster Hospital, London

Can HIV be cured? (how about long term Drug free remission?)

IAS 2015 Towards an HIV Cure symposium Vancouver. Distinct HIV Genetic Populations in Effector Memory T Cells after Prolonged Therapy

Pathogenesis Update Robert F. Siliciano, MD, PhD

Tim-3 as a target for tumor immunotherapy

Dr Jintanat Ananworanich

Changes in cellular HIV DNA levels during the MONET trial: 144 Weeks of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs

Approaching a Cure Daniel R. Kuritzkes, MD

Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques

Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals

SUPPLEMENTAL INFORMATIONS

Immunophenotyping of rheumatoid arthritis reveals a linkage between. HLA-DRB1 genotype, CXCR4 expression on memory CD4 + T cells, and

Supporting Information

Fluorochrome Panel 1 Panel 2 Panel 3 Panel 4 Panel 5 CTLA-4 CTLA-4 CD15 CD3 FITC. Bio) PD-1 (MIH4, BD) ICOS (C398.4A, Biolegend) PD-L1 (MIH1, BD)

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence

HIV/Sexual Health Clinical Education Session

T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection

CHRONIC HEPATITIS B VIRUS Prospects for Cure

Alessandra Franco MD PhD UCSD School of Medicine Department of Pediatrics Division of Allergy Immunology and Rheumatology

T Memory Stem Cells: A Long-term Reservoir for HIV-1

What s New in Acute HIV Infection?

Parallel session IVB. Chair: Hans Wildiers

HIV 101: Fundamentals of HIV Infection

CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 +

Impact of Vorinostat Treatment of Non- Hodgkin s Lymphoma on HIV-1 Latent Reservoir

HIV AND INFLAMMATION: A NEW THREAT

Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

I declare that I have no financial conflicts of interest

The Swarm: Causes and consequences of HIV quasispecies diversity

Oral Abstracts. BIC Coadministered

Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design

Immunologic Failure and Chronic Inflammation. Steven G. Deeks Professor of Medicine University of California, San Francisco

Summary Report for HIV Random Clinical Trial Conducted in

Time taken to reach undetectable viral loads in therapy-naïve HIV patients commencing ART

How HIV Causes Disease Prof. Bruce D. Walker

Transcription:

Impact of ART in Primary HIV infection on T cell immune exhaustion in Gut- associated lymphoid tissue: Implications for HIV persistence THORNHILL J, MARTIN GE, HERRERA C, HOPKINS E, FIDLER S, FRATER J

Background The HIV reservoir is the main barrier to HIV cure Gut- associated lymphoid tissue (GALT) harbours the largest anatomical HIV- 1 reservoir The immune environment in GALT may support viral persistence in the gut Early ART in Primary HIV infection limits HIV reservoir and enhances immune recovery in blood Immune exhaustion of both CD4 and CD8 T cells may support HIV persistence in the gut Novel agents that target immune exhaustion -? potential targets for HIV cure strategies

What is T Cell exhaustion Persistent antigen During chronic viral infections, such as HIV, HCV, and EBV T cell exhaustion is a state Over- expression of T cell of multiple dysfunction that arises inhibitory receptors during many chronic PD- 1, infections Tim- 3, Lag- 3, and TIGIT, cancer. etc. It is associated with poor effector function of T cells Drivers of exhaustion Chronic Inflammation IL- 6, IL- 21 & IFN- 1 Antigen Adapted from Pauken, K et al. Cell. 2015 TCR INDUCTION OF INHIBITORY GENES T - cell ALTERED TRANSCIPTIONAL PROFILE Physiological Consequences Exhaustion is characterized by a progressive loss of T cell function Limited proliferative capacity Reduced cytokine production Poor control of infection

T- cell exhaustion and HIV Exhausted CD4+T- cells are enriched for HIV- 1 DNA in peripheral blood 1,2 T cell exhaustion limits antiviral function of CD8+ T cells 3,4 CD4+ and CD8+ T- cell exhaustion predicts disease progression and viral rebound on treatment cessation 3,4,5 1. Fromentin, R. et al Plos Pathogens 2016 2. Banga, R. et al Nature medicine 2016 3. Hoffmann, F. et al. Plos Pathogens 2016 4. Chew, G. et al. Plos Pathogens 2016 5. Hurst, J. et al. Nature Communications 2015

Aims Characterise the markers of immune function & exhaustion markers in Gut- Associated Lymphoid Tissue (GALT) of individuals commenced on ART in PHI compared with controls Examine the relationship between immune exhaustion in tissue and peripheral blood

Methods Clinical Cohorts HEATHER gut sub- study St Mary s Hospital London HIV+ samples Translational Gastroenterology Unit (TGU) Oxford HIV- samples Clinical Samples ü HIV- 1 infection 1. Peripheral ü Started Blood on ART Sampling in PHI ü Individuals 2. Gut undergoing Biopsies routine Ø Rectum endoscopy at JR Hospital Ø Terminal Oxford Ileum Laboratory Methods Collagenase Digestion ü On ART for >1 year ü No known hx of HIV infection or IBD ü No hx of Cells IBD from blood and biopsies used to assess biomarkers of immune function (exhaustion markers) on CD4 & CD8 cells using Flow Cytometry CD4/CD8 & Exhaustion Markers: PD- 1, Tim- 3, TIGIT PD- 1

Results Baseline characteristics HEATHER gut sub- study HIV+ samples TGU HIV- samples Median age in years 40 (36-56) 59 (55-70) Male 13 9 Median days from PHI to ART HEATHER start gut sub- study 28 (20-35) Translational - St Mary s Hospital Gastroenterology Unit Median months on ART at Biopsy 26 (19-34) - London (TGU) Oxford Median CD4 count at time of Biopsy HIV+ samples 707 (634-957) HIV- samples - Median CD4/CD8 ratio at time of Biopsy 1.0 (0.6-1.5) - Median nadir CD4 count 490 (320-696) - ART 3 rd Agent: PI NNRTI INSTI 26 individuals were included in this analysis n=13 n=13 1 (8) 3 (25) 8 (67) -

Immune recovery CD4/CD8 by Anatomical Site HIV- CONTROLS HIV POSITIVE Rectum T. Ileum PBMC p values calculated using Kruskal-Wallis test. Corrected for multiple Comparisons

Differences in CD4/CD8 recovery by HIV Status In treated PHI, CD4/CD8 ratio in rectal HIV+GALT is comparable with controls, however, CD4/CD8 remains RECTUM TERMINAL ILEUM PERIPHERAL BLOOD (PBMC) significantly lower in terminal ileum GALT HIV- HIV+ p values calculated using Mann- Whitney test

Immune exhaustion on CD4+ T- cells across anatomical sites HIV- CONTROLS HIV POSITIVE GALT PBMC Higher expression of all exhaustion markers is observed in GALT sites compared to PBMCs p values calculated using Mann- Whitney test

PD- 1 expression on CD4+ T- cells PD- 1 HIV+ HIV- No difference in PD- 1 expression on CD4+ T- cells between HIV+ and HIV- PBMCs Higher PD- 1 expression in HIV GALT compared to HIV- controls p values calculated using Mann- Whitney test

TIGIT expression on CD4+ T- cells TIGIT HIV+ No difference in TIGIT expression on CD4+ T- cells between HIV+ and HIV- PBMCs Higher TIGIT expression in HIV GALT compared to HIV- controls HIVp values calculated using Mann- Whitney test

Tim- 3 expression on CD4+ T- cells TIM- 3 HIV+ No difference in Tim- 3 expression on CD4+ T- cells in PBMCs or GALT between HIV+ and HIV- samples HIVp values calculated using Mann- Whitney test

Immune exhaustion on CD8+ T- cells in GALT CD8+TIGIT expression was higher in HIV+ GALT compared to HIV- GALT (p=0.01). HIV+ HIV- The greatest difference observed in the TI (p=0.04) data not shown No differences were noted for PD- 1 and Tim- 3 expression p values calculated using Mann- Whitney test

Exhaustion markers expression in peripheral blood does not reflect immune exhaustion in GALT PD- 1 expression in blood does not correlate with expression in GALT PBMC vs Rectum PBMC vs T. Ileum T. Ileum vs Rectum Data for TIGIT andtim- 3 not shown r= spearman's rho

Summary Early ART results in restoration of CD4/CD8 in rectal tissue but not in the terminal ileum Greater expression of exhaustion markers is seen in gut tissue compared to peripheral blood Greater exhaustion marker expression was observed in HIV+ gut tissue compared to controls, despite early ART. No difference were seen in exhaustion marker expression in peripheral blood between HIV+ and HIV- participants

Conclusions Differential expression of immune exhaustion markers on T- cells by anatomical compartment may reflect and support differential levels of HIV persistence in GALT despite early ART initiation in PHI. Measurement of immune exhaustion markers in blood does not reflect expression in GALT and highlights the importance of tissue sampling in HIV cure studies.

Acknowledgements Thank you to all HEATHER study participants Prof Sarah Fidler, Prof Klenerman & Prof John Frater, P Dr Jonno Hoare & Simon Peake Endoscopy at St Marys The Frater Group Emily Hopkins Matt Jones Genevieve Martin Jodi Meyerowitz Matt Pace Chansavath Phetsouphanh Nicola Robinson Chris Willberg Prof Kholoud Porter, Wolfgang Stohr & all the CHERUB collaborators Carolina Herrera & Natalia Olejniczak at Imperial College BHIVA & MRC for their funding

Back- up Slides

Expression of exhaustion markers on CD4+ T cells in Gut associated lymphoid tissue (GALT) Rectum T.Ileum p values calculated using Wilcoxon matched-pairs signed rank test

Higher expression of exhaustion markers on CD4 T- cells in rectal GALT compared with TI in HIV infected GALT 80 p=0.01 p=0.09 p=0.03 p=0.38 % expression 60 40 20 0-20 Rectal PD-1 TI PD-1 Rectal TIGIT TI TIGIT Rectal Tim-3 TI Tim-3 Rectal HLA DR TI HLA-DR Wilcoxon test used to calculate p values, error bars represent mean and SD Rectum TI

Initial HIV- 1 DNA results HIV copies per million CD4 cells HIV copies per million gut cells HEATHE HIV 1 DNA (Log copies/million CD4) 15000 10000 5000 0 TI HIV-1 DNA Rectum HIV-1 DNA HIV 1 DNA (Log copies/million cells) 1500 1000 500 0 TI HIV-1 DNA Rectum HIV-1 DNA Median PBMC HIV-1 DNA cells Median Rectal HIV-1 DNA (n=3) Median T. Ileum HIV-1 DNA (n=3) ART 3 rd Agent: PI NNRTI INSTI

P24 expression by CD4+ T cell type CXCR5+/- Gut PD1+/- % p24 expression 8 6 4 2 0 2.0 1.5 1.0 0.5 0.0-2 CXCR5+ p24+ CXCR5- p24+ -0.5 CD4+ PD1+ p24+ CD4+ PD1- p24+

Exhaustion marker expression on CD4+ T- cells in terminal ileum and rectum compared to PBMC Expression of all exhaustion markers is higher in each GALT site compared to PBMCs p values calculated using Kruskal-Wallis test. Corrrected for multiple comparisons Combined HIV= and HIV- samples

P24 expression by anatomical site 6 TI Vs Rectum p24 % p24 expression 4 2 0-2 Rectum CD4+ p24+ TI CD4+ p24+